annual EBITDA:
-$92.74M+$50.42M(+35.22%)Summary
- As of today (August 22, 2025), ANAB annual EBITDA is -$92.74 million, with the most recent change of +$50.42 million (+35.22%) on December 31, 2024.
- During the last 3 years, ANAB annual EBITDA has fallen by -$38.49 million (-70.94%).
- ANAB annual EBITDA is now -1911.05% below its all-time high of $5.12 million, reached on December 31, 2014.
Performance
ANAB EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
-$25.57M+$1.36M(+5.06%)Summary
- As of today (August 22, 2025), ANAB quarterly EBITDA is -$25.57 million, with the most recent change of +$1.36 million (+5.06%) on June 30, 2025.
- Over the past year, ANAB quarterly EBITDA has increased by +$14.16 million (+35.64%).
- ANAB quarterly EBITDA is now -176.35% below its all-time high of $33.49 million, reached on December 31, 2020.
Performance
ANAB quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$83.73M+$14.16M(+14.46%)Summary
- As of today (August 22, 2025), ANAB TTM EBITDA is -$83.73 million, with the most recent change of +$14.16 million (+14.46%) on June 30, 2025.
- Over the past year, ANAB TTM EBITDA has increased by +$68.92 million (+45.15%).
- ANAB TTM EBITDA is now -977.97% below its all-time high of $9.54 million, reached on September 30, 2021.
Performance
ANAB TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
ANAB EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +35.2% | +35.6% | +45.1% |
| 3 y3 years | -70.9% | +6.1% | +12.1% |
| 5 y5 years | +2.4% | -13.7% | +5.2% |
ANAB EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -70.9% | +35.2% | -181.9% | +41.6% | at high | +45.9% |
| 5 y | 5-year | -406.4% | +35.2% | -176.3% | +41.6% | -978.0% | +45.9% |
| alltime | all time | -1911.0% | +35.2% | -176.3% | +41.6% | -978.0% | +45.9% |
ANAB EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$25.57M(-5.1%) | -$83.73M(-14.5%) |
| Mar 2025 | - | -$26.93M(+197.0%) | -$97.89M(-13.0%) |
| Dec 2024 | -$92.74M(-35.2%) | -$9.07M(-59.1%) | -$112.55M(-18.2%) |
| Sep 2024 | - | -$22.16M(-44.2%) | -$137.68M(-9.8%) |
| Jun 2024 | - | -$39.73M(-4.5%) | -$152.65M(+0.1%) |
| Mar 2024 | - | -$41.60M(+21.7%) | -$152.48M(-1.4%) |
| Dec 2023 | -$143.16M(+36.0%) | -$34.19M(-7.9%) | -$154.70M(+6.0%) |
| Sep 2023 | - | -$37.14M(-6.1%) | -$145.87M(+5.9%) |
| Jun 2023 | - | -$39.56M(-9.7%) | -$137.78M(+9.8%) |
| Mar 2023 | - | -$43.81M(+72.7%) | -$125.45M(+11.2%) |
| Dec 2022 | -$105.26M(+94.0%) | -$25.37M(-12.7%) | -$112.82M(-4.6%) |
| Sep 2022 | - | -$29.05M(+6.7%) | -$118.22M(+24.1%) |
| Jun 2022 | - | -$27.23M(-12.7%) | -$95.27M(+40.8%) |
| Mar 2022 | - | -$31.18M(+1.3%) | -$67.66M(+23.6%) |
| Dec 2021 | -$54.26M(+196.3%) | -$30.77M(+405.0%) | -$54.72M(-673.8%) |
| Sep 2021 | - | -$6.09M(-1712.2%) | $9.54M(-211.3%) |
| Jun 2021 | - | $378.00K(-102.1%) | -$8.57M(-72.8%) |
| Mar 2021 | - | -$18.24M(-154.5%) | -$31.44M(+34.8%) |
| Dec 2020 | -$18.31M(-80.7%) | $33.49M(-238.4%) | -$23.32M(-70.5%) |
| Sep 2020 | - | -$24.20M(+7.6%) | -$78.93M(-10.7%) |
| Jun 2020 | - | -$22.50M(+122.5%) | -$88.34M(-4.5%) |
| Mar 2020 | - | -$10.11M(-54.3%) | -$92.47M(-13.6%) |
| Dec 2019 | -$95.04M | -$22.12M(-34.2%) | -$107.02M(+2.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2019 | - | -$33.61M(+26.2%) | -$104.46M(+19.2%) |
| Jun 2019 | - | -$26.63M(+8.0%) | -$87.64M(+16.3%) |
| Mar 2019 | - | -$24.66M(+26.1%) | -$75.36M(+13.5%) |
| Dec 2018 | -$59.88M(+113.0%) | -$19.56M(+16.4%) | -$66.41M(+23.1%) |
| Sep 2018 | - | -$16.80M(+17.0%) | -$53.95M(+16.8%) |
| Jun 2018 | - | -$14.35M(-8.6%) | -$46.20M(+34.5%) |
| Mar 2018 | - | -$15.70M(+121.0%) | -$34.35M(+20.1%) |
| Dec 2017 | -$28.11M(+687.9%) | -$7.10M(-21.4%) | -$28.60M(+16.2%) |
| Sep 2017 | - | -$9.04M(+261.1%) | -$24.61M(+48.4%) |
| Jun 2017 | - | -$2.50M(-74.8%) | -$16.59M(+42.3%) |
| Mar 2017 | - | -$9.95M(+219.3%) | -$11.66M(+317.6%) |
| Dec 2016 | -$3.57M(-21.3%) | -$3.12M(+206.4%) | -$2.79M(-13.0%) |
| Sep 2016 | - | -$1.02M(-142.0%) | -$3.21M(+13.9%) |
| Jun 2016 | - | $2.42M(-323.9%) | -$2.82M(-38.2%) |
| Mar 2016 | - | -$1.08M(-69.4%) | -$4.55M(+49.4%) |
| Dec 2015 | -$4.53M(-188.5%) | -$3.53M(+465.3%) | -$3.05M(-380.7%) |
| Sep 2015 | - | -$625.00K(-191.2%) | $1.09M(-79.4%) |
| Jun 2015 | - | $685.00K(+61.2%) | $5.26M(-13.1%) |
| Mar 2015 | - | $425.00K(-29.3%) | $6.06M(+17.0%) |
| Dec 2014 | $5.12M(-225.5%) | $601.00K(-83.1%) | $5.18M(+13.1%) |
| Sep 2014 | - | $3.55M(+139.9%) | $4.58M(+345.7%) |
| Jun 2014 | - | $1.48M(-426.7%) | $1.03M(-326.7%) |
| Mar 2014 | - | -$453.00K | -$453.00K |
| Dec 2013 | -$4.08M | - | - |
FAQ
- What is AnaptysBio, Inc. annual EBITDA?
- What is the all time high annual EBITDA for AnaptysBio, Inc.?
- What is AnaptysBio, Inc. annual EBITDA year-on-year change?
- What is AnaptysBio, Inc. quarterly EBITDA?
- What is the all time high quarterly EBITDA for AnaptysBio, Inc.?
- What is AnaptysBio, Inc. quarterly EBITDA year-on-year change?
- What is AnaptysBio, Inc. TTM EBITDA?
- What is the all time high TTM EBITDA for AnaptysBio, Inc.?
- What is AnaptysBio, Inc. TTM EBITDA year-on-year change?
What is AnaptysBio, Inc. annual EBITDA?
The current annual EBITDA of ANAB is -$92.74M
What is the all time high annual EBITDA for AnaptysBio, Inc.?
AnaptysBio, Inc. all-time high annual EBITDA is $5.12M
What is AnaptysBio, Inc. annual EBITDA year-on-year change?
Over the past year, ANAB annual EBITDA has changed by +$50.42M (+35.22%)
What is AnaptysBio, Inc. quarterly EBITDA?
The current quarterly EBITDA of ANAB is -$25.57M
What is the all time high quarterly EBITDA for AnaptysBio, Inc.?
AnaptysBio, Inc. all-time high quarterly EBITDA is $33.49M
What is AnaptysBio, Inc. quarterly EBITDA year-on-year change?
Over the past year, ANAB quarterly EBITDA has changed by +$14.16M (+35.64%)
What is AnaptysBio, Inc. TTM EBITDA?
The current TTM EBITDA of ANAB is -$83.73M
What is the all time high TTM EBITDA for AnaptysBio, Inc.?
AnaptysBio, Inc. all-time high TTM EBITDA is $9.54M
What is AnaptysBio, Inc. TTM EBITDA year-on-year change?
Over the past year, ANAB TTM EBITDA has changed by +$68.92M (+45.15%)